Cantor Fitzgerald Upgrades TrovaGene (TROV) to Buy

August 8, 2016 7:28 AM EDT
Get Alerts TROV Hot Sheet
Price: $2.10 -6.67%

Rating Summary:
    5 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 17 | New: 14
Trade TROV Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Cantor Fitzgerald upgraded TrovaGene (NASDAQ: TROV) from Hold to Buy with a price target of $7.00 (from $5.00).

For an analyst ratings summary and ratings history on TrovaGene click here. For more ratings news on TrovaGene click here.

Shares of TrovaGene closed at $5.20 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst PT Change, Upgrades

Related Entities

Cantor Fitzgerald

Add Your Comment